Krystal Biotech, Inc. KRYS Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s change in inventories?
- Krystal Biotech, Inc. (KRYS) reported change in inventories of $243K in Q1 2026.
- How has Krystal Biotech, Inc.'s change in inventories changed year-over-year?
- Krystal Biotech, Inc.'s change in inventories decreased by 82.6% year-over-year, from $1.4M to $243K.
- What does change in inventories mean?
- The net change in the value of goods held in stock during the period.
- How do you interpret change in inventories?
- An increase in inventory often signals anticipated demand growth or supply chain buffering, while a decrease may signal efficient inventory management or potential supply shortages.
- How does change in inventories compare across companies?
- Standard across manufacturing and biotech firms, though biotech inventory levels are typically lower than traditional manufacturing.